Vaccines for the New Millennium Act of 2005

Summary

Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries. Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund. Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries. Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 14 September 2005

   Introduced

   Introduced in House

   Source: IntroReferral

2. 14 September 2005

   Introduced

   Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 14 September 2005

   Introduced

   Referred to the Committee on Ways and Means, and in addition to the Committees on International Relations, Energy and Commerce, Small Business, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

4. 14 September 2005

   Introduced

   Introduced in House

   Source: IntroReferral

5. 7 October 2005

   Referred

   Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

   Source: Committee

6. 17 October 2005

   Referred

   Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 14 September 2005 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 14 September 2005

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 14 September 2005

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 14 September 2005

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Visclosky, Peter J. [D-IN-1] · D · Sponsor
• Rep. King, Peter T. [R-NY-2] · R · Cosponsor
• Rep. Rangel, Charles B. [D-NY-15] · D · Cosponsor
• Rep. Jefferson, William J. [D-LA-2] · D · Cosponsor
• Rep. McGovern, James P. [D-MA-2] · D · Cosponsor
• Rep. Payne, Donald M. [D-NJ-10] · D · Cosponsor
• Rep. Davis, Danny K. [D-IL-7] · D · Cosponsor
• Rep. McNulty, Michael R. [D-NY-23] · D · Cosponsor
• Rep. Lee, Barbara [D-CA-12] · D · Cosponsor
• Rep. Sherman, Brad [D-CA-32] · D · Cosponsor
• Rep. McDermott, Jim [D-WA-7] · D · Cosponsor
• Rep. Carson, Julia [D-IN-7] · D · Cosponsor
• Rep. Wexler, Robert [D-FL-19] · D · Cosponsor
• Rep. Blumenauer, Earl [D-OR-3] · D · Cosponsor
• · hsba00 · Standing
• · hsif00 · Standing
• · hssm00 · Standing
• · hsfa00 · Standing
• · hswm00 · Standing

Related records

• related to ← Vaccines for the New Millennium Act of 2005